| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |